TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CTNM

Contineum Therapeutics, Inc.

Healthcare · Biotechnology

13.50$ +2.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Contineum Therapeutics, Inc. (CTNM): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/29/2026.

Next report 10/29/2026
Last report 07/30/2026
Earnings surprise by quarter (%)
Q1 24 · -166.9 % 24 Q2 24 · -11.4 % 24 Q3 24 · 4.8 % 24 Q4 24 · -30.2 % 24 Q1 25 · -8.8 % 25 Q2 25 · -51.2 % 25 Q3 25 · 2.2 % 25 Q4 25 · 24.6 % 25 Q1 26 · 26.4 % 26 Q2 26 · 13.0 % 26

EPS estimate beaten

Full history 5 of 11 quarters (45%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/14/2026 Contineum Therapeutics, Inc. (CTNM): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/30/2026 Contineum Therapeutics, Inc. (CTNM): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/13/2026 Contineum Therapeutics, Inc. (CTNM): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?